FDA urges consumers not to buy tianeptine products due to serious risks as lawmakers call for ‘immediate action’

Opioid epidemicEducators and caregiversHealthcare ProfessionalSubstance use disorderPublic healthCOVID-19MiPC News
Written By Denise Kolakowski

Between January 1, 2019, and December 31, 2023, about 1,100 “human exposures” involving tianeptine were reported to US poison centers, Maggie Maloney, a spokesperson for America’s Poison Centers.

Learn more
Denise Kolakowski
Previous

Expanded recall for potential Listeria monocytogenes contamination
Next

CPSC Warns Consumers to Immediately Stop Using Pedetid High-Powered Magnetic Ball Sets Due to Ingestion Hazard